Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results

What happened

Waters Corporation reported third-quarter 2026 revenue of $1.767 billion, $14 million above the guidance midpoint, with organic revenue growth of 9% as reported and adjusted earnings per share of $4.10, up 21%. It raised every component of its 2026 guidance, including the revenue midpoint by $43 million.

Confirmed

Global impact / market context

Revenue above guidance and higher earnings indicate stronger sales and profitability than the company had expected. Raising guidance signals management expects this strength to continue through 2026; if demand holds, Waters could generate more revenue and cash available to fund operations or investment.

Analyst inference

Growth was broad across reported business highlights: Analytical Sciences rose 8%, Biosciences reagents grew at a high-single-digit rate, and Advanced Diagnostics microbiology grew at a mid-single-digit rate. These figures suggest demand across several product areas, rather than one disclosed division alone, supported the quarter.

Analyst inference

What to watch

1. Check the full-year 2026 guidance details when available, especially whether the higher revenue outlook is accompanied by stronger earnings expectations and persists in subsequent results. Analyst inference
2. Waters said it will provide a starting 2027 growth framework on its earnings call; compare that outlook with the raised 2026 expectations and stated demand trends. Confirmed
3. Watch whether instrument, chemistry, and testing demand continues to support Analytical Sciences growth, since a slowdown there could weaken revenue momentum despite the higher full-year guidance. Analyst inference

Evidence

• Original source link unavailable